{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,10]],"date-time":"2026-04-10T06:44:56Z","timestamp":1775803496378,"version":"3.50.1"},"reference-count":45,"publisher":"Walter de Gruyter GmbH","issue":"1","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,4,8]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec id=\"j_rir-2026-0007_s_006\">\n                    <jats:title>Background and Objective<\/jats:title>\n                    <jats:p>Early diagnosis of systemic sclerosis (SSc) is challenging due to heterogeneous presentation and lack of reliable biomarkers, resulting in many patients being diagnosed during hospitalization with advanced disease and severe complications. We aimed to characterize the clinical presentation, diagnostic pathway, and outcomes of patients first diagnosed with SSc during hospitalization.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"j_rir-2026-0007_s_007\">\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      We retrospectively reviewed adult patients newly diagnosed with SSc during hospitalization (January 2016-July 2023), including those referred for SSc evaluation or with SSc features identified during admission for other diagnoses. Patients previously diagnosed as outpatients were excluded. Clinical presentations were compared between patients admitted for SSc-related reasons\n                      <jats:italic>vs<\/jats:italic>\n                      . those admitted for other reasons subsequently diagnosed with SSc.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"j_rir-2026-0007_s_008\">\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Thirty-five patients were included (mean age 60.4 \u00b1 12.8 years; 60% women). Most (68.6%) were incidentally diagnosed with SSc during hospitalization for unrelated conditions. Common indications for hospitalization included pericardial effusion (22.9%), progressive pulmonary hypertension (17.1%), and progressive interstitial lung disease (14.3%). Approximately 60% of both hospitalized patients in both groups initially saw general practitioners before were rheumatological referral. Age, sex, symptom duration, most clinical features, length of stay, hospital costs, and outcomes were similar between patients admitted for SSC-related\n                      <jats:italic>vs<\/jats:italic>\n                      . non-SSc-related reasons, except for greater gastrointestinal involvement in the latter group (\n                      <jats:italic>P<\/jats:italic>\n                      = 0.02).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"j_rir-2026-0007_s_009\">\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Hospitalized patients first diagnosed with SSc predominantly present with diffuse cutaneous involvement and advanced cardiopulmonary complications. Most cases are identified during hospitalization for unrelated conditions, highlighting the need for increased clinical vigilance and systematic SSc evaluation in at-risk hospitalized patients to enable early detection and improve outcomes.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1515\/rir-2026-0007","type":"journal-article","created":{"date-parts":[[2026,3,30]],"date-time":"2026-03-30T13:16:05Z","timestamp":1774876565000},"page":"24-33","source":"Crossref","is-referenced-by-count":0,"title":["Hospital-based first diagnoses of systemic sclerosis: Defining initial clinical presentations and diagnostic pathways"],"prefix":"10.1515","volume":"7","author":[{"given":"Teerapat","family":"Luengthanapol","sequence":"first","affiliation":[{"name":"Department of Medicine, Faculty of Medicine, Khon Kaen University , Khon Kaen , Thailand"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tippawan","family":"Onchan","sequence":"additional","affiliation":[{"name":"Department of Medicine, Faculty of Medicine, Khon Kaen University , Khon Kaen , Thailand"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patnarin","family":"Pongkulkiat","sequence":"additional","affiliation":[{"name":"Department of Medicine, Faculty of Medicine, Khon Kaen University , Khon Kaen , Thailand"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ajanee","family":"Mahakkanukrauh","sequence":"additional","affiliation":[{"name":"Department of Medicine, Faculty of Medicine, Khon Kaen University , Khon Kaen , Thailand"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Siraphop","family":"Suwannaroj","sequence":"additional","affiliation":[{"name":"Department of Medicine, Faculty of Medicine, Khon Kaen University , Khon Kaen , Thailand"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1964-4389","authenticated-orcid":false,"given":"Chingching","family":"Foocharoen","sequence":"additional","affiliation":[{"name":"Department of Medicine, Faculty of Medicine, Khon Kaen University , Khon Kaen , Thailand"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"374","published-online":{"date-parts":[[2026,3,30]]},"reference":[{"key":"2026041005450740867_j_rir-2026-0007_ref_001","doi-asserted-by":"crossref","unstructured":"Anbiaee N, Tafakhori Z. Early diagnosis of progressive systemic sclerosis (scleroderma) from a panoramic view: report of three cases. Dentomaxillofac Radiol. 2011;40:457\u2013462.","DOI":"10.1259\/dmfr\/64340754"},{"key":"2026041005450740867_j_rir-2026-0007_ref_002","doi-asserted-by":"crossref","unstructured":"Foocharoen C, Ngamjarus C, Pattanittum P, et al. Incidence and prevalence of systemic sclerosis in Thailand in year 2017\u20132020: a database from the Ministry of Public Health. Clin Rheumatol. 2023;42:1767\u20131774.","DOI":"10.1007\/s10067-023-06550-7"},{"key":"2026041005450740867_j_rir-2026-0007_ref_003","unstructured":"National Academies of Sciences E, Division H and M, Services B on HC, Disability C on SID and Scleroderma. In: Selected Immune Disorders and Disability. Available from: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK584477."},{"key":"2026041005450740867_j_rir-2026-0007_ref_004","doi-asserted-by":"crossref","unstructured":"Foocharoen C, Thavornpitak Y, Mahakkanukrauh A, et al. Admission rate and characteristics of hospitalized systemic connective tissue disorders: analysis from a nationwide Thailand healthcare database. Int J Rheum Dis. 2013;16:41\u201346.","DOI":"10.1111\/1756-185X.12031"},{"key":"2026041005450740867_j_rir-2026-0007_ref_005","doi-asserted-by":"crossref","unstructured":"Netwijitpan S, Foocharoen C, Mahakkanukrauh A, Suwannaroj S, Nanagara R. Indications for hospitalization and in-hospital mortality in Thai systemic sclerosis. Clin Rheumatol. 2013;32:361\u2013367.","DOI":"10.1007\/s10067-012-2131-0"},{"key":"2026041005450740867_j_rir-2026-0007_ref_006","doi-asserted-by":"crossref","unstructured":"Bellando-Randone S, Matucci-Cerinic M. Very early systemic sclerosis. Best Pract Res Clin Rheumatol. 2019;33:101428.","DOI":"10.1016\/j.berh.2019.101428"},{"key":"2026041005450740867_j_rir-2026-0007_ref_007","doi-asserted-by":"crossref","unstructured":"van den Hoogen F, Khanna D, Fransen J, et al. 2013 classification criteria for systemic sclerosis: an American College of Rheumatology\/European League against Rheumatism collaborative initiative. Arthritis Rheum. 2013;65:2737\u20132747.","DOI":"10.1002\/art.38098"},{"key":"2026041005450740867_j_rir-2026-0007_ref_008","doi-asserted-by":"crossref","unstructured":"Blaja E, Jordan S, Mihai CM, et al. The Challenge of Very Early Systemic Sclerosis: A Combination of Mild and Early Disease? J Rheumatol. 2021;48:82\u201386.","DOI":"10.3899\/jrheum.190976"},{"key":"2026041005450740867_j_rir-2026-0007_ref_009","doi-asserted-by":"crossref","unstructured":"Caetano J, Batista F, Amaral MC, et al. Acute hospitalization in a cohort of patients with systemic sclerosis: a 10-year retrospective cohort study. Rheumatol Int. 2022;42:1393\u20131402.","DOI":"10.1007\/s00296-021-04983-4"},{"key":"2026041005450740867_j_rir-2026-0007_ref_010","unstructured":"Foocharoen C, Mahakkanukrauh A, Suwannaroj S, et al. Clinical characteristics and mortality in systemic sclerosis: a comparison between early- and late-referred diseases. J Med Assoc Thai. 2014;97:28\u201335."},{"key":"2026041005450740867_j_rir-2026-0007_ref_011","doi-asserted-by":"crossref","unstructured":"Foocharoen C, Peansukwech U, Mahakkanukrauh A, et al. Clinical characteristics and outcomes of 566 Thais with systemic sclerosis: A cohort study. Int J Rheum Dis. 2020;23:945\u2013957.","DOI":"10.1111\/1756-185X.13859"},{"key":"2026041005450740867_j_rir-2026-0007_ref_012","unstructured":"LeRoy EC, Black C, Fleischmajer R, et al. Scleroderma (systemic sclerosis): classification, subsets and pathogenesis. J Rheumatol. 1988;15:202\u2013205."},{"key":"2026041005450740867_j_rir-2026-0007_ref_013","doi-asserted-by":"crossref","unstructured":"Korn JH, Mayes M, Matucci Cerinic M, et al. Digital ulcers in systemic sclerosis: prevention by treatment with bosentan, an oral endothelin receptor antagonist. Arthritis Rheum. 2004;50:3985\u20133993.","DOI":"10.1002\/art.20676"},{"key":"2026041005450740867_j_rir-2026-0007_ref_014","doi-asserted-by":"crossref","unstructured":"Young A, Namas R, Dodge C, Khanna D. Hand Impairment in Systemic Sclerosis: Various Manifestations and Currently Available Treatment. Curr Treatm Opt Rheumatol. 2016;2:252\u2013269.","DOI":"10.1007\/s40674-016-0052-9"},{"key":"2026041005450740867_j_rir-2026-0007_ref_015","doi-asserted-by":"crossref","unstructured":"Humbert M, Kovacs G, Hoeper MM, et al. 2022 ESC\/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension. Eur Heart J. 2022;43:3618\u20133731.","DOI":"10.1093\/eurheartj\/ehac237"},{"key":"2026041005450740867_j_rir-2026-0007_ref_016","doi-asserted-by":"crossref","unstructured":"Witayakom W, Pussadhamma B, Tumsatan P, et al. Prevalence, Classification, and Outcomes of Pulmonary Hypertension in Thai Systemic Sclerosis. J Med Assoc Thai. 2021;104:S88\u201396.","DOI":"10.35755\/jmedassocthai.2021.S04.00050"},{"key":"2026041005450740867_j_rir-2026-0007_ref_017","doi-asserted-by":"crossref","unstructured":"Savarino E, Furnari M, de Bortoli N, et al. Gastrointestinal involvement in systemic sclerosis. Presse Med. 2014;43:e279-e291.","DOI":"10.1016\/j.lpm.2014.03.029"},{"key":"2026041005450740867_j_rir-2026-0007_ref_018","doi-asserted-by":"crossref","unstructured":"Werakiat J, Pussadhamma B, Mahakkanukrauh A, et al. Clinical courses and predictors of left ventricular systolic dysfunction in systemic sclerosis: A cohort study. Rheumatol Immunol Res. 2024;5:107\u2013116.","DOI":"10.1515\/rir-2024-0014"},{"key":"2026041005450740867_j_rir-2026-0007_ref_019","doi-asserted-by":"crossref","unstructured":"Foocharoen C, Tonsawan P, Pongkulkiat P, et al. Management review of scleroderma renal crisis: An update with practical pointers. Mod Rheumatol. 2023;33:12\u201320.","DOI":"10.1093\/mr\/roac028"},{"key":"2026041005450740867_j_rir-2026-0007_ref_020","doi-asserted-by":"crossref","unstructured":"Dalakas MC. Inflammatory Muscle Diseases. N Engl J Med. 2015;373:393\u2013394.","DOI":"10.1056\/NEJMc1506827"},{"key":"2026041005450740867_j_rir-2026-0007_ref_021","unstructured":"Ahmed I, Alley WD, Chauhan S, et al. Hypertensive Crisis. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 [cited 2026 Jan 19]. Available from: http:\/\/www.ncbi.nlm.nih.gov\/books\/NBK507701\/"},{"key":"2026041005450740867_j_rir-2026-0007_ref_022","doi-asserted-by":"crossref","unstructured":"McMahan ZH, Kulkarni S, Chen J, et al. Systemic sclerosis gastrointestinal dysmotility: risk factors, pathophysiology, diagnosis and management. Nat Rev Rheumatol. 2023;19:166\u2013181.","DOI":"10.1038\/s41584-022-00900-6"},{"key":"2026041005450740867_j_rir-2026-0007_ref_023","doi-asserted-by":"crossref","unstructured":"Distler O, Allanore Y, Denton CP, et al. Factors influencing early referral, early diagnosis and management in patients with diffuse cutaneous systemic sclerosis. Rheumatology (Oxford). 2018;57:813\u2013817.","DOI":"10.1093\/rheumatology\/kex504"},{"key":"2026041005450740867_j_rir-2026-0007_ref_024","doi-asserted-by":"crossref","unstructured":"Tian J, Kang S, Zhang D, et al. Global, regional, and national incidence and prevalence of systemic sclerosis. Clin Immunol. 2023;248:109267.","DOI":"10.1016\/j.clim.2023.109267"},{"key":"2026041005450740867_j_rir-2026-0007_ref_025","doi-asserted-by":"crossref","unstructured":"Mahakkanukrauh A, Ngamjarus C, Pattanittum P, et al. Epidemiology of systemic sclerosis in the Asia-Pacific region: a systematic review and meta-analysis. Ann Med. 2025;57:2479238.","DOI":"10.1080\/07853890.2025.2479238"},{"key":"2026041005450740867_j_rir-2026-0007_ref_026","doi-asserted-by":"crossref","unstructured":"Roberts-Thomson PJ, Jones M, Hakendorf P, et al. Scleroderma in South Australia: epidemiological observations of possible pathogenic significance. Intern Med J. 2001;31:220\u2013229.","DOI":"10.1046\/j.1445-5994.2001.00048.x"},{"key":"2026041005450740867_j_rir-2026-0007_ref_027","doi-asserted-by":"crossref","unstructured":"Eason RJ, Tan PL, Gow PJ. Progressive systemic sclerosis in Auckland: a ten year review with emphasis on prognostic features. Aust N Z J Med. 1981;11:657\u2013662.","DOI":"10.1111\/j.1445-5994.1981.tb03542.x"},{"key":"2026041005450740867_j_rir-2026-0007_ref_028","doi-asserted-by":"crossref","unstructured":"Geirsson AJ, Steinsson K, Guthmundsson S, et al. Systemic sclerosis in Iceland. A nationwide epidemiological study. Ann Rheum Dis. 1994;53:502\u2013505.","DOI":"10.1136\/ard.53.8.502"},{"key":"2026041005450740867_j_rir-2026-0007_ref_029","unstructured":"Ferri C, Valentini G, Cozzi F, et al. Systemic sclerosis: demographic, clinical, and serologic features and survival in 1,012 Italian patients. Medicine (Baltimore). 2002;81139\u201381153."},{"key":"2026041005450740867_j_rir-2026-0007_ref_030","doi-asserted-by":"crossref","unstructured":"Tyndall A, Mueller-Ladner U, Matucci-Cerinic M. Systemic sclerosis in Europe: first report from the EULAR Scleroderma Trials And Research (EUSTAR) group database. Ann Rheum Dis. 2005;64:1107.","DOI":"10.1136\/ard.2005.036038"},{"key":"2026041005450740867_j_rir-2026-0007_ref_031","unstructured":"Delisle VC, Hudson M, Baron M, et al. Sex and time to diagnosis in systemic sclerosis: an updated analysis of 1,129 patients from the Canadian scleroderma research group registry. Clin Exp Rheumatol. 2014;32:S-10-14."},{"key":"2026041005450740867_j_rir-2026-0007_ref_032","doi-asserted-by":"crossref","unstructured":"Reveille JD, Fischbach M, McNearney T, et al. Systemic sclerosis in 3 US ethnic groups: a comparison of clinical, sociodemographic, serologic, and immunogenetic determinants. Semin Arthritis Rheum. 2001;30:332\u2013346.","DOI":"10.1053\/sarh.2001.20268"},{"key":"2026041005450740867_j_rir-2026-0007_ref_033","doi-asserted-by":"crossref","unstructured":"Foocharoen C, Watcharenwong P, Netwijitpan S, et al. Relevance of clinical and autoantibody profiles in systemic sclerosis among Thais. Int J Rheum Dis. 2017;20:1572\u20131581.","DOI":"10.1111\/1756-185X.13060"},{"key":"2026041005450740867_j_rir-2026-0007_ref_034","doi-asserted-by":"crossref","unstructured":"Cavazzana I, Vojinovic T, Airo\u2019 P, et al. Systemic Sclerosis-Specific Antibodies: Novel and Classical Biomarkers. Clin Rev Allergy Immunol. 2023;64:412\u2013430.","DOI":"10.1007\/s12016-022-08946-w"},{"key":"2026041005450740867_j_rir-2026-0007_ref_035","doi-asserted-by":"crossref","unstructured":"Potera J, Manadan AM. Reasons for hospitalization and in-hospital mortality in adults with systemic sclerosis: Analysis of the National Inpatient Sample. J Scleroderma Relat Disord. 2022;7:189\u2013196.","DOI":"10.1177\/23971983221083225"},{"key":"2026041005450740867_j_rir-2026-0007_ref_036","doi-asserted-by":"crossref","unstructured":"Foocharoen C, Pussadhamma B, Mahakkanukrauh A, et al. Asymptomatic cardiac involvement in Thai systemic sclerosis: prevalence and clinical correlations with non-cardiac manifestations (preliminary report). Rheumatology (Oxford). 2015;54:1616\u20131621.","DOI":"10.1093\/rheumatology\/kev096"},{"key":"2026041005450740867_j_rir-2026-0007_ref_037","doi-asserted-by":"crossref","unstructured":"Meune C, Avouac J, Wahbi K, et al. Cardiac involvement in systemic sclerosis assessed by tissue-doppler echocardiography during routine care: A controlled study of 100 consecutive patients. Arthritis Rheum. 2008;58:1803\u20131809.","DOI":"10.1002\/art.23463"},{"key":"2026041005450740867_j_rir-2026-0007_ref_038","unstructured":"Langley RL, Treadwell EL. Cardiac tamponade and pericardial disorders in connective tissue diseases: case report and literature review. J Natl Med Assoc. 1994;86:149\u2013153."},{"key":"2026041005450740867_j_rir-2026-0007_ref_039","doi-asserted-by":"crossref","unstructured":"Kru\u017eliak P, Kov\u00e1\u010dov\u00e1 G, Balogh \u0160. Pericardial effusion as a first sign of systemic scleroderma. Cor et Vasa. 2012;54:e258\u2013e260.","DOI":"10.1016\/j.crvasa.2012.05.014"},{"key":"2026041005450740867_j_rir-2026-0007_ref_040","doi-asserted-by":"crossref","unstructured":"Kitchongcharoenying P, Foocharoen C, Mahakkanukrauh A, et al. Pericardial fluid profiles of pericardial effusion in systemic sclerosis patients. Asian Pac J Allergy Immunol. 2013;31:314\u2013 319.","DOI":"10.12932\/AP0305.31.4.2013"},{"key":"2026041005450740867_j_rir-2026-0007_ref_041","doi-asserted-by":"crossref","unstructured":"Hosoya H, Derk CT. Clinically Symptomatic Pericardial Effusions in Hospitalized Systemic Sclerosis Patients: Demographics and Management. Biomed Res Int. 2018;2018:6812082.","DOI":"10.1155\/2018\/6812082"},{"key":"2026041005450740867_j_rir-2026-0007_ref_042","doi-asserted-by":"crossref","unstructured":"Steen V. The heart in systemic sclerosis. Curr Rheumatol Rep. 2004;6:137\u2013140.","DOI":"10.1007\/s11926-004-0058-4"},{"key":"2026041005450740867_j_rir-2026-0007_ref_043","doi-asserted-by":"crossref","unstructured":"Marie I, Dominique S, Levesque H, et al. Esophageal involvement and pulmonary manifestations in systemic sclerosis. Arthritis Rheum. 2001;45:346\u2013354.","DOI":"10.1002\/1529-0131(200108)45:4<346::AID-ART347>3.0.CO;2-L"},{"key":"2026041005450740867_j_rir-2026-0007_ref_044","doi-asserted-by":"crossref","unstructured":"Herrick AL, Lunt M, Whidby N, et al. Observational study of treatment outcome in early diffuse cutaneous systemic sclerosis. J Rheumatol. 2010;37:116\u2013124.","DOI":"10.3899\/jrheum.090668"},{"key":"2026041005450740867_j_rir-2026-0007_ref_045","doi-asserted-by":"crossref","unstructured":"Walker UA, Tyndall A, Czirj\u00e1k L, et al. Clinical risk assessment of organ manifestations in systemic sclerosis: a report from the EULAR Scleroderma Trials And Research group database. Ann Rheum Dis. 2007;66:754\u2013763.","DOI":"10.1136\/ard.2006.062901"}],"container-title":["Rheumatology and Immunology Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.degruyterbrill.com\/document\/doi\/10.1515\/rir-2026-0007\/xml","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.degruyterbrill.com\/document\/doi\/10.1515\/rir-2026-0007\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,10]],"date-time":"2026-04-10T05:45:23Z","timestamp":1775799923000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.degruyterbrill.com\/document\/doi\/10.1515\/rir-2026-0007\/html"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,1]]},"references-count":45,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,3,30]]},"published-print":{"date-parts":[[2026,4,8]]}},"alternative-id":["10.1515\/rir-2026-0007"],"URL":"https:\/\/doi.org\/10.1515\/rir-2026-0007","relation":{},"ISSN":["2719-4523"],"issn-type":[{"value":"2719-4523","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,1]]}}}